We are excited to announce our appearance in the Colorectal Disease peer reviewed medical journal of two article abstracts, one is entitled ‘eXroid Electrotherapy: a low-risk treatment for all grades of internal haemorrhoids’.
In this article we outline how the eXroid electrotherapy treatment successfully treats all 4 grades of haemorrhoids (1-4). Our article also importantly demonstrates, that while haemorrhoids cause significant morbidity and place a significant burden on the NHS, eXroid is an attractive out-patient based treatment option, with a very low risk of complications compared to other treatments.
The research follows 812 patients, including 503 men, 309 women with a median age of 54yrs, who were aged between 18 and 96. These individuals were treated between March 2019 and November 2020, and our article discusses how they reacted to the eXroid treatment.
– eXroid electrotherapy can be used successfully in all four grades of internal haemorrhoid disease.
– eXroid electrotherapy can be used in those patients taking anticoagulants without the need to stop these prior to treatment
– The risk of serious adverse events for the eXroid procedure is very low.
The eXroid® treatment takes 30 minutes or less. Effects can be felt from immediately and no waiting for a referral
The procedure is supported and carried out by the UK's leading specialist consultant surgeons in CQC registered clinics
The eXroid® procedure is low risk, as it requires no anaesthetic, cutting or stitching
Get back to your life straightaway, with no time off work needed after the eXroid® procedure
eXroid® electrotherapy is subject to NICE guidance (IPG525 & MIB201), is rated as Outstanding by the CQC and carries the CE mark